1. Introduction
===============

The application of the Vilsmeier-Haack (VH) reagent (POCl~3~/DMF) for formylation of a variety of both aromatic and heteroaromatic substrates is well documented \[[@B1-molecules-15-07472]\]. Besides this, the reagent has also been extensively used for effecting various chemical transformations with other classes of compounds. Many of these reactions have led to novel and convenient routes for the synthesis of various heterocyclic compounds \[[@B2-molecules-15-07472]\]. A notable example that finds significant application in heterocyclic chemistry is the synthesis of 4-formylpyrazoles from the double formylation of hydrazones with the VH reagent \[[@B3-molecules-15-07472],[@B4-molecules-15-07472]\]. These observations, coupled with the recent developments in the simple synthesis of pyrazole derivatives \[[@B5-molecules-15-07472]\], especially 4-functionalized 1,3-diphenylpyrazoles as antibacterial \[[@B6-molecules-15-07472]\], anti-inflammatory \[[@B7-molecules-15-07472]\], antiparasitic \[[@B8-molecules-15-07472]\], and antidiabetic drugs \[[@B9-molecules-15-07472]\], prompted us to undertake the synthesis of pyrazole-4-carbaldehyde derivatives using the VH reagent.

It has been known for some time that fluorine atoms can lead to unexpected biological activity results due to the special properties of the fluorine atom, such as the high electronegativity of fluorine and the high carbon-fluorine bond energy \[[@B10-molecules-15-07472]\]. As a consequence, trifluoromethyl-containing molecules have been found considerable utilization in the agrochemical and pharmaceutical industries \[[@B10-molecules-15-07472],[@B11-molecules-15-07472],[@B12-molecules-15-07472]\], for example, pyrazole derivatives bearing trifluoromethyl groups, such as fipronil and analogs \[[@B13-molecules-15-07472],[@B14-molecules-15-07472]\] are widely used phenylpyrazole insecticides applied in granular or bait form for residential and commercial control of turf grass pests, and celecoxib \[[@B15-molecules-15-07472]\], widely prescribed to treat acute or chronic inflammation by providing symptomatic pain relief, are examples of such compounds. In this paper, we show a simple and efficient synthetic method using the VH reagent \[[@B4-molecules-15-07472],[@B16-molecules-15-07472],[@B17-molecules-15-07472]\] that affords a series of novel 1-\[(2,6-dichloro-4-trifluoromethyl)phenyl\]-3-aryl-1*H*-pyrazole-4-carbaldehydes.

2. Results and Discussion
=========================

Phenylhydrazine **3** was synthesized from 2,6-dichloro-4-trifluoromethylphenylamine (**1**) through diazotization, reduction and hydration ([Scheme 1](#molecules-15-07472-f002){ref-type="fig"}). The reducing reagent plays an important role in the reaction. When the intermediate **2** was reduced by SnCl~2~, an almost quantitative yield of product was obtained. Use of Na~2~S~2~O~3~ or Zn as reducing reagents led to lower yields.

![Synthesis of phenylhydrazine **3**.](molecules-15-07472-g002){#molecules-15-07472-f002}

Phenylhydrazones **5** were next synthesized in almost quantitative yields by the reaction between the phenylhydrazine **3** and 3 or 4-substituted aryl methyl ketones, regardless of whether the ketones contained electron-withdrawing or electron-donating groups ([Scheme 2](#molecules-15-07472-f003){ref-type="fig"}).

![Synthesis of phenylhydrazones **5**.](molecules-15-07472-g003){#molecules-15-07472-f003}

X-ray diffraction
-----------------

To verify the structural assignment compound **5b** was selected as an example for an X-ray diffraction study ([Figure 1](#molecules-15-07472-f001){ref-type="fig"} and [Table 1](#molecules-15-07472-t001){ref-type="table"}). The purified product **5b** was dissolved in 50 % ethanol/acetone (1:1 v/v) and kept at room temperature for 5 days and single crystals of **5b** were thus formed. CCDC 685556 contains the supplementary crystallographic data for this comound \[[@B18-molecules-15-07472]\].

![ORTEP drawing of the compound **5b** showing the atom numbering scheme.](molecules-15-07472-g001){#molecules-15-07472-f001}

molecules-15-07472-t001_Table 1

###### 

Crystal data and summary of data collection and structure refinement.

  Compound                                C~15~ H~10~ Cl~3~ F~3~ N~2~
  --------------------------------------- ----------------------------------------
  Color                                   Colorless
  Formula weight                          381.60
  Crystal system                          Monoclinic
  Temperature,°                           25(298K)
  Cell constants                          
  a (Å)                                   16.8770(7)
  b (Å)                                   8.0054(8)
  c (Å)                                   24.119(2)
  α (˚)                                   90
  β (˚)                                   99.654(2)
  γ (˚)                                   90
  Volume (Å^3^)                           3212.5(4)
  Formula units                           8
  Calculated density (g/cm^-3^)           1.578
  F(000)                                  1536
  Absorption coefficient, mμ^-3^          0.599
  Limiting indices                        -20\<=h\<=16, -7\<=k\<=9, -27\<=l\<=28
  Reflections collected / unique          8110 / 2841 \[R(int) = 0.0402\]
  Absorption correction                   Semi-empirical from equivalents
  Max. and min. transmission              0.9370 and 0.8314
  Refinement method                       Full-matrix least-squares on F^2^
  Data / restraints / parameters          2841 / 0 / 208
  Goodness-of-fit on F^2^                 1.015
  Final R indices                         R~1~ = 0.1641, wR~2~ = 0.5152
  Largest diff. peak and hole (e Å^-3^)   0.869 and -0.919

The Vilsmeier cyclization of hydrazones could provide an efficient route for the preparation of 1*H* -pyrazole-4-carbaldehydes. The reaction was carried out at 80--90 °C for 4 h using 3 equiv. of the VH reagent, affording a series of novel 1-\[(2,6-dichloro-4-trifluoromethyl)phenyl\]-3-aryl-1*H*-pyrazole-4-carbaldehydes in good yields ([Scheme 3](#molecules-15-07472-f004){ref-type="fig"}). The results are shown in [Table 2](#molecules-15-07472-t002){ref-type="table"}. 1*H*-Pyrazole-4-carbaldehydes **6** cannot be obtained if the DMF used is not anhydrous.

![Synthesis of 1*H*-pyrazole-4-carbaldehydes **6**.](molecules-15-07472-g004){#molecules-15-07472-f004}

molecules-15-07472-t002_Table 2

###### 

Synthesis of 1*H*--pyrazole-4-carbaldehydes.

  ------- ---------------------------------- ----------------- ----------------
  Entry   Ar                                 Products(**6**)   Yield(%) *^a^*
  1       C~6~H~5~                           **6a**            89
  2       4-ClC~6~H~4~                       **6b**            88
  3       3-ClC~6~H~4~                       **6c**            83
  4       4-BrC~6~H~4~                       **6d**            86
  5       3-BrC~6~H~4~                       **6e**            82
  6       4-MeOC~6~H~4~                      **6f**            83
  7       4-CF~3~C~6~H~4~                    **6g**            86
  8       4-NO~2~C~6~H~4~                    **6h**            85
  9       ![](molecules-15-07472-i001.jpg)   **6i**            81
  ------- ---------------------------------- ----------------- ----------------

*^a^* Isolated yields with regard to the quantity of hydrazones **5**

3. Experimental
===============

3.1. General
------------

All melting points were determined on an XT-4A apparatus and are uncorrected. TLC was performed using precoated silica gel GF~254~ (0.25mm), column chromatography was performed using silica gel (200--300 mesh). The ^1^H- and ^13^C-NMR spectra were measured at 25 °C at 300 and 75 MHz, respectively, on a Bruker Advance 300 spectrometer, using TMS as internal standard. *J*-values are given in Hz. The IR spectra were taken on a Bruker Vector 55 spectrometer. Elemental analyses were carried out with an EA 1112 elemental analyzer. All the reagents used were AR grade.

3.2. Synthesis of (2,6-Dichloro-4-trifluoromethyl)phenylhydrazine *(**3**)*
---------------------------------------------------------------------------

2,6-Dichloro-4-trifluoromethylphenylamine (**1**, 1.73 g, 7.5 mmol) was dissolved in concentrated HCl (10 mL) and water (10 mL) and cooled to 0 °C, sodium nitrite (0.62 g, 9.0 mmol) was added and the yellow solution was stirred at 0 °C for 2 h to get a solution of diazotizated compound **2**. SnCl~2~ (2.85 g, 15 mmol) was dissolved in concentrated HCl (10 mL) and cooled to 7 °C, then the diazotizated solution of **2** was added slowly dropwise. After 1 h of reaction, the precipitate was filtered, washed with water and air-dried. The precipitate was neutralized by 25% NaOH in water to pH 8, the light yellow sediment was collected and air-dried to afford a brown solid **3** (1.53 g, 83%), m.p. 65--67 °C. ^1^H-NMR (CDCl~3~) δ: 7.52 (s, 2H, Ar-H), 5.85 (s, 1H, NH), 3.86 (br, 2H, NH~2~); ^13^C- NMR (CDCl~3~) δ: 137.1, 132.5 (q, *J* = 33.8 Hz), 130.3, 123.8, 122.3 (q, *J* = 271.8 Hz); IR (KBr) ν: 3517, 3418, 1622, 1583, 1492, 1329, 1281, 1144, 883 cm^-1^.

3.3. General procedure for synthesis of N-(2,6-Dichloro-4-trifluoromethyl)phenyl-N'-(1-phenyl-ethylidene) hydrazines ***5a-i***
-------------------------------------------------------------------------------------------------------------------------------

To a solution of compound **3** (12 mmol) in absolute C~2~H~5~OH (30 mL) was added substituted acetophenone **4** (10 mmol). Two drops of concentrated HCl were added to a stirred solution, and the mixture was refluxed for 1 h. The solid obtained on cooling was filtered, dried and recrystallized from C~2~H~5~OH to give compounds **5a-i**.

*N-(2,6-Dichloro-4-trifluoromethyl)phenyl-N'-(1-phenylethylidene)hydrazine* (**5a**): White solid, m.p. 90--91 °C; ^1^H-NMR (CDCl~3~) δ: 7.82 (d, *J* = 3.6 Hz, 2H, N'-Ar-H), 7.67 (s, 1H, NH), 7.58 (s, 2H, N-Ar-H), 7.34--7.42 (m, 3H, N'-Ar-H), 2.35 (s, 3H, CH~3~); ^13^C-NMR (CDCl~3~) δ: 147.2, 140.8, 136.1, 132.5 (q, *J* = 33.8 Hz), 127.3, 126.8, 126.0, 125.8, 123.8, 122.3 (q, *J* = 271.8 Hz), 11.7; IR (KBr) ν: 3350, 3072, 2927, 1603, 1538, 1492, 1390, 1351, 1311, 1114, 1009, 887 cm^-1^.

*N-(2,6-Dichloro-4-trifluoromethyl)phenyl-N'-\[1-(4-chlorophenyl)ethylidene\]hydrazine* (**5b**): White solid, m.p. 118--120 °C; ^1^H-NMR (CDCl~3~) δ: 7.68--7.76 (m, 3H, N'-Ar-H and NH), 7.58 (s, 2H, N-Ar-H), 7.34--7.37 (m, 2H, N'-Ar-H), 2.33 (s, 3H, CH~3~); ^13^C NMR (CDCl~3~) δ: 146.1, 140.7, 136.3, 134.5 (q, *J* = 33.5 Hz), 128.3, 126.7, 126.2, 126.0, 123.9, 121.8 (q, *J* = 271.8 Hz), 11.8; IR (KBr) ν: 3360, 3070, 2924, 1605, 1532, 1490, 1392, 1352, 1303, 1114, 1004, 884 cm^-1^.

*N-(2,6-Dichloro-4-trifluoromethyl)phenyl-N'-\[1-(3-chlorophenyl)ethylidene\]hydrazine* (**5c**): White solid, m.p. 118--120 °C; ^1^H-NMR (CDCl~3~) δ: 7.83 (s, 1H, N'-Ar-H), 7.71--7.76 (m, 2H, N'-Ar-H and NH), 7.58 (s, 2H, N-Ar-H), 7.36--7.40 (m, 2H, N'-Ar-H), 2.32 (s, 3H, CH3); ^13^C-NMR (CDCl~3~) δ: 146.1, 140.7, 136.3, 133.5 (q, *J* = 33.3 Hz), 129.2, 128.3, 127.5, 126.7, 126.1, 125.6, 123.9, 122.1 (q, *J* = 271.8 Hz), 12.1; IR (KBr) ν: 3358, 3073, 2926, 1603, 1536, 1489, 1390, 1352, 1313, 1108, 1011, 886 cm^-1^.

*N-(2,6-Dichloro-4-trifluoromethyl)phenyl-N'-\[1-(4-bromophenyl)-ethylidene\]hydrazine* (**5d**): White solid, m.p. 114--115 °C; ^1^H-NMR (CDCl~3~) δ: 7.65--7.69 (m, 3H, N'-Ar-H and NH), 7.58 (s, 2H, N-Ar-H), 7.48--7.52 (m, 2H, N'-Ar-H), 2.33 (s, 3H, CH~3~); ^13^C-NMR (CDCl~3~) δ: 146.5, 141.7, 134.3, 132.5 (q, *J* = 33.5 Hz), 127.6, 127.1, 126.7, 125.6, 123.9, 121.9 (q, *J* = 271.8 Hz), 11.7; IR (KBr) ν: 3362, 3074, 2928, 1606, 1540, 1495, 1393, 1354, 1308, 1106, 1012, 887 cm^-1^.

*N-(2,6-Dichloro-4-trifluoromethyl)phenyl-N'-\[1-(3-bromophenyl)ethylidene\]hydrazine* (**5e**): White solid, m.p. 114--115 °C; ^1^H-NMR (CDCl~3~) δ: 7.94 (s, 1H, N'-Ar-H), 7.70--7.75 (m, 2H, N'-Ar-H and NH), 7.58 (s, 2H, N-Ar-H), 7.46--7.49 (m, 2H, N'-Ar-H), 2.32 (s, 3H, CH~3~); ^13^C-NMR (CDCl~3~) δ: 147.1, 141.9, 139.3, 132.3 (q, *J* = 33.5 Hz), 128.3, 127.6, 127.1, 126.7, 126.0, 124.6, 123.9, 121.9 (q, *J* = 271.8 Hz), 11.9; IR (KBr) ν: 3360, 3072, 2924, 1600, 1538, 1492, 1390, 1356, 1307, 1115, 1019, 889 cm^-1^.

*N-(2,6-Dichloro-4-trifluoromethyl)phenyl-N'-\[1-(4-methoxyphenyl)ethylidene\]-hydrazine* (**5f**): White solid, m.p. 89--90 °C; ^1^H-NMR (CDCl~3~) δ: 7.81 (s, 1H, N'-Ar-H), 7.79 (s, 1H, N'-Ar-H), 7.67 (s, 1H, NH), 7.58 (m, 2H, N-Ar-H), 6.73--6.89 (m, 2H, N'-Ar-H), 3.83 (s, 3H, OCH~3~), 2.32 (s, 3H, CH~3~). ^13^C-NMR (CDCl~3~) δ: 158.1, 147.5, 136.2, 133.6 (q, *J* = 33.6 Hz), 127.8, 126.2, 125.6, 124.7, 121.9 (q, *J* = 270.2 Hz), 114.2, 55.1, 11.7; IR (KBr) ν: 3355, 3072, 2925, 1603, 1530, 1489, 1391, 1351, 1307, 1112, 1016, 887 cm^-1^.

*N-(2,6-Dichloro-4-trifluoromethyl)phenyl-N'-\[1-(4-trifluoromethylphenyl)-ethylidene\]hydrazine* (**5g**): White solid, m.p. 165--166 °C; ^1^H-NMR (CDCl~3~) δ: 7.91 (d, *J* = 8.4 Hz, 2H, N'-Ar-H), 7.78 (s, 1H, NH), 7.59--7.65 (s, 4H, N' and N-Ar-H), 2.36 (s, 3H, CH~3~); ^13^C-NMR (CDCl~3~) δ: 145.5, 144.7, 133.5 (q, *J* = 32.6 Hz), 130.4 (q, *J* = 32.1 Hz), 126.3, 125.8, 125.2, 124.6, 124.4, 123.2 (q, *J* = 270.2 Hz), 121.8 (q, *J* = 272.6 Hz), 11.9; IR (KBr) ν: 3351, 3070, 2926, 1601, 1535, 1490, 1389, 1350, 1313, 1116, 1021, 889 cm^-1^.

*N-(2,6-Dichloro-4-trifluoromethyl)phenyl-N'-\[1-(4-nitrophenyl)ethylidene\]hydrazine* (**5h**): Yellowish solid, m.p. 146--147 °C; ^1^H-NMR (CDCl~3~) δ: 8.24 (d, *J* = 6.0 Hz, 2H, N'-Ar-H), 7.88--7.97 (m, 3H, N'-Ar-H and NH), 7.60 (s, 2H, N-Ar-H), 2.38 (s, 3H, CH~3~); ^13^C-NMR (CDCl~3~) δ: 147.5, 144.3, 143.9, 140.4, 132.8 (q, *J* = 33.6 Hz), 126.5, 125.1, 124.7, 123.6, 120.9 (q, *J* = 272.6 Hz), 11.8; IR (KBr) ν: 3320, 3073, 2926, 1583, 1513, 1393, 1339, 1307, 1117, 890 cm^-1^.

*N-(2,6-Dichloro-4-trifluoromethyl)phenyl-N'-\[1-(6-methoxy-naphthalen-2-yl)-ethylidene\]hydrazine* (**5i**): White solid, m.p. 191--193 °C; ^1^H-NMR (CDCl~3~) δ: 8.11 (d, *J* = 6.2 Hz, 1H, N'-Ar-H), 8.00 (s, 1H, N'-Ar-H), 7.71--7.78 (m, 3H, N'-Ar-H and NH), 7.58 (s, 2H, N-Ar-H), 7.14-7.17 (m, 2H, N'-Ar-H), 3.84 (s, 3H, OCH~3~), 2.43 (s, 3H, CH~3~); ^13^C-NMR (CDCl~3~) δ: 157.9, 147.5, 134.6, 133.2 (q, *J* = 32.5 Hz), 129.6, 128.2, 126.7, 126.2, 126.1, 125.3, 124.8, 123.8, 123.7, 121.7 (q, *J* = 271.6 Hz), 118.7, 105.5, 55.0, 11.7; IR (KBr) ν: 3353, 3069, 2938, 1602, 1528, 1487, 1390, 1346, 1305, 1127, 1026, 889 cm^-1^.

3.4. General procedure for synthesis of 1-\[(2,6-dichloro-4-trifluoromethyl)phenyl\]-3-aryl-1H-pyrazole-4- carbaldehydes ***6a-i***
-----------------------------------------------------------------------------------------------------------------------------------

POCl~3~ (0.5 g, 3.0 mmol) was added dropwise to an ice-cold stirred solution of hydrazone **5** (1.0 mmol) in dry DMF (4 mL), the reaction mixture was allowed to attain room temperature and then heated at 80 °C for 4 h. The resulting mixture was poured onto crushed ice, neutralized with dilute sodium hydroxide and left standing overnight. The pale yellow precipitate obtained was purified by flash column chromatography with ethyl acetate--petroleum ether mixture to yield the products **6a-i.**

*1-\[(2,6-Dichloro-4-trifluoromethyl)phenyl\]-3-phenyl-1H-pyrazole-4-carbaldehyde* (**6a**): White solid, m.p. 147--149 °C; ^1^H-NMR (CDCl~3~) δ: 10.11 (s, 1H, CHO), 8.22 (s, 1H, pyrazole H), 7.79--7.83 (m, 4H, 1 and 3-Ar-H), 7.27--7.54 (m, 3H, 3-Ar-H); ^13^C-NMR (CDCl~3~) δ: 182.4, 153.8, 137.8, 135.0, 133.9 (q, *J* = 33.8 Hz), 129.0, 126.1, 125.8, 125.3, 124.6, 123.7, 122.6, 121.9 (q, *J* = 271.8 Hz); IR (KBr) ν: 3107, 3062, 2843, 1695, 1602, 1531, 1403, 1310, 1131, 850, 719 cm^-1^; Anal. Calcd. for C~17~H~9~Cl~2~F~3~N~2~O: C, 53.01; H, 2.36; N, 7.27. Found: C, 53.30; H, 2.45; N, 7.33%.

*1-\[(2,6-Dichloro-4-trifluoromethyl)phenyl\]-3-(4-chlorophenyl)-1H-pyrazole-4-carbaldehyde* (**6b**): White solid, m.p. 108--110 °C; ^1^H-NMR (CDCl~3~) δ: 10.08 (s, 1H, CHO), 8.22 (s, 1H, pyrazole H), 7.79--7.83 (m, 4H, 1 and 3-Ar-H), 7.45--7.48 (m, 2H, 3-Ar-H); ^13^C-NMR (CDCl~3~) δ: 183.6, 152.8, 138.8, 136.0, 133.8 (q, *J* = 33.8 Hz), 129.1, 128.5, 126.1, 125.8, 125.3, 123.7, 122.6, 121.9 (q, *J* = 271.8 Hz); IR (KBr) ν: 3107, 3060, 2845, 1695, 1600, 1529, 1401, 1314, 1130, 858, 719 cm^-1^; Anal. Calcd. for C~17~H~8~Cl~3~F~3~N~2~O: C, 48.66; H, 1.92; N, 6.68. Found: C, 48.77; H, 2.03; N, 6.60%.

*1-\[(2,6-Dichloro-4-trifluoromethyl)phenyl\]-3-(3-chlorophenyl)-1H-pyrazole-4-carbaldehyde* (**6c**): White solid, m.p. 105--106 °C; ^1^H-NMR (CDCl~3~) δ: 10.09 (s, 1H, CHO), 8.21 (s, 1H, pyrazole H), 7.83--7.91 (m, 3H, 1 and 3-Ar-H), 7.31--7.62 (m, 3H, 3-Ar-H); ^13^C-NMR (CDCl~3~) δ: 183.6, 152.8, 137.8, 136.0, 159.6, 133.8 (q, *J* = 33.8 Hz), 129.1, 128.5, 128.1, 126.1, 125.8, 125.2, 123.6, 122.7, 121.8 (q, *J* = 271.8 Hz); IR (KBr) ν: 3106, 3062, 2840, 1696, 1602, 1530, 1403, 1310, 1134, 856, 719 cm^-1^; Anal. Calcd. for C~17~H~8~Cl~3~F~3~N~2~O: C, 48.66; H, 1.92; N, 6.68. Found: C, 48.81; H, 1.90; N, 6.80%.

*1-\[(2,6-Dichloro-4-trifluoromethyl)phenyl\]-3-(4-bromophenyl)-1H-pyrazole-4-carbaldehyde* (**6d**): White solid, m.p. 116--118 °C; ^1^H-NMR (CDCl~3~) δ: 10.08 (s, 1H, CHO), 8.22 (s, 1H, pyrazole H), 7.74--7.79 (m, 4H, 1 and 3-Ar-H), 7.61--7.64 (m, 2H, 3-Ar-H); ^13^C-NMR (CDCl~3~) δ: 183.6, 152.8, 138.8, 136.0, 134.6, 133.8 (q, *J* = 33.8 Hz), 129.1, 128.5, 125.8, 125.3, 123.5, 122.6, 121.9 (q, *J* = 271.8 Hz); IR (KBr) ν: 3108, 3063, 2841, 1697, 1604, 1532, 1407, 1315, 1131, 858, 719 cm^-1^; Anal. Calcd. for C~17~H~8~BrCl~2~F~3~N~2~O: C, 44.00; H, 1.74; N, 6.04. Found: C, 43.87; H, 1.79; N, 5.96%.

*1-\[(2,6-Dichloro-4-trifluoromethyl)phenyl\]-3-(3-bromophenyl)-1H-pyrazole-4-carbaldehyde* (**6e**): White solid, m.p. 110--112 °C; ^1^H-NMR (CDCl~3~) δ: 10.09 (s, 1H, CHO), 8.22 (s, 1H, pyrazole H), 7.79--7.83 (m, 4H, 1 and 3-Ar-H), 7.59--7.62 (m, 1H, 3-Ar-H), 7.35--7.38 (m, 1H, 3-Ar-H); ^13^C-NMR (CDCl~3~) δ: 182.9, 153.8, 139.0, 136.7, 134.2, 133.8 (q, *J* = 33.8 Hz), 129.1, 128.5, 126.1, 125.9, 125.3, 123.7, 123.3, 122.6, 121.8 (q, *J* = 271.8 Hz); IR (KBr) ν: 3106, 3062, 2840, 1695, 1602, 1530, 1401, 1313, 1132, 856, 719 cm^-1^; Anal. Calcd. for C~17~H~8~BrCl~2~F~3~N~2~O: C, 44.00; H, 1.74; N, 6.04. Found: C, 43.70; H, 1.83; N, 6.36%.

*1-\[(2,6-Dichloro-4-trifluoromethyl)phenyl\]-3-(4-methoxyphenyl)-1H-pyrazole-4-carbaldehyde* (**6f**): White solid, m.p. 75--77 °C; ^1^H-NMR (CDCl~3~) δ: 10.08 (s, 1H, CHO), 8.20 (s, 1H, pyrazole H), 7.76--7.79 (m, 4H, 1 and 3-Ar-H), 7.00--7.03 (m, 2H, 3-Ar-H), 3.87 (s, 3H, OCH~3~); ^13^C-NMR (CDCl~3~) δ: 183.2, 160.4, 154.5, 136.1, 134.9, 133.8 (q, *J* = 33.8 Hz), 130.0, 128.2, 125.8, 125.7, 122.8, 121.9 (q, *J* = 271.6 Hz), 113.9, 55.0; IR (KBr) ν: 3110, 3060, 2963, 2850, 1695, 1600, 1530, 1403, 1312, 1130, 858, 719 cm^-1^; Anal. Calcd. for C~18~H~11~C~l2F3~N~2~O~2~: C, 52.07; H, 2.67; N, 6.75. Found: C, 52.10; H, 2.65; N, 6.78%.

*1-\[(2,6-Dichloro-4-trifluoromethyl)phenyl\]-3-(4-trifluoromethylphenyl)-1H-pyrazole-4-carbaldehyde* (**6g**): White solid, m.p. 88--90 °C; ^1^H-NMR (CDCl~3~) δ: 10.11(s, 1H, CHO), 8.25 (s, 1H, pyrazole H), 8.01--8.03 (m, 2H, 3-Ar-H), 7.74--7.83 (m, 4H, 1 and 3-Ar-H); ^13^C-NMR (CDCl~3~) δ: 183.2, 151.8, 148.3, 139.1, 137.8, 136.9, 135.0, 133.9 (q, *J* = 33.8 Hz), 129.8 (q, *J* = 32.6 Hz), 129.0, 126.1, 123.7 (q, *J* = 270.1 Hz), 122.6, 121.9 (q, *J* = 271.8 Hz); IR (KBr) ν: 3110, 3060, 2842, 1695, 1600, 1528, 1400, 1313, 1130, 858, 719 cm^-1^; Anal. Calcd. for C~18~H~8~C~l2F6~N~2~O: C, 47.71; H, 1.78; N, 6.18. Found: C, 47.84; H, 1.85; N, 6.23%.

*1-\[(2,6-Dichloro-4-trifluoromethyl)phenyl\]-3-(4-nitrophenyl)-1H-pyrazole-4-carbaldehyde* (**6h**): Yellowish solid, m.p. 206--208 °C; ^1^H-NMR (CDCl~3~) δ: 10.12 (s, 1H, CHO), 8.33--8.36 (m, 2H, 3-Ar-H), 8.27(s, 1H, pyrazole H), 8.13--8.15 (m, 2H, 3-Ar-H), 7.82 (s, 2H, 1-Ar-H); ^13^C-NMR (CDCl~3~) δ: 183.2, 151.8, 148.3, 139.1, 137.8, 136.9, 135.0, 133.8 (q, *J* = 33.8 Hz), 129.6, 126.1, 123.7, 122.6, 121.9 (q, *J* = 271.6 Hz); IR (KBr) ν: 3106, 3062, 2843, 1695, 1602, 1530, 1403, 1310, 1132, 858, 719 cm^-1^; Anal. Calcd. for C~17~H~8~C~l2F3~N~3~O~3~: C, 47.47; H, 1.87; N, 9.77. Found: C, 47.56; H, 1.93; N, 9.62%.

*1-\[(2,6-Dichloro-4-trifluoromethyl)phenyl\]-3-(6-methoxy-naphthalen-2-yl)-1H-pyrazole-4-carb-aldehyde* (**6i**): White solid, m.p. 144--146 °C; ^1^H-NMR (CDCl~3~) δ: 10.19(s, 1H, CHO), 8.25 (s, 1H, pyrazole H), 7.80--7.92 (m, 5H, 1 and 3-Ar-H), 7.19--7.23 (m, 3H, 3-Ar-H), 3.94 (s, 3H, OCH~3~); ^13^C- NMR (CDCl~3~) δ: 183.2, 158.2, 155.0, 136.4, 134.9, 134.7, 133.8 (q, *J* = 33.8 Hz), 129.7, 128.3, 128.2, 127.0, 126.4, 125.8, 125.4, 123.5, 122.1, 121.9 (q, *J* = 271.6 Hz), 119.2, 105.4, 55.0; IR (KBr) ν: 3108, 3062, 2963, 2840, 1695, 1600, 1528, 1400, 1313, 1130, 858, 719 cm^-1^; Anal. Calcd. for C~22~H~13~Cl~2~F~3~N~2~O~2~: C, 56.79; H, 2.82; N, 6.02. Found: C, 56.65; H, 2.93; N, 6.15%.

4. Conclusions
==============

In conclusion, The Vilsmeier cyclization of hydrazones provided an efficient route for the preparation of 1*H*-pyrazole-4-carbaldehydes, and we have successfully developed a general method for the synthesis in good yields of a series of 1-\[(2,6-dichloro-4-trifluoromethyl)phenyl\]-3-aryl-1*H*-pyrazole-4-carbaldehydes **6a-i** using the Vilsmeier-Haack reagent. The structures of all the title compounds have been confirmed by elemental analysis, ^1^H-NMR and ^13^C-NMR and in addition, the structure of intermediate **5b** was confirmed by X-ray crystallography.
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